Eylea 8 mg is the first and only anti-vascular endothelial growth factor (VEGF) treatment in the EU with treatment intervals of up to 6 months for both patients with nAMD and DME.

(RTTNews) - Palantir Technologies Inc. (PLTR) has announced a strategic product partnership with The Nuclear Company to co-develop NOS, the first AI-powered, real-time software system designed ...

On Friday, June 27, we will see the last annual Russel Reconstitution before the index provider switches to reconstitutions twice a year. We’ve covered before that, typically, Russell Reconstitution ...

Gen Z and Millennial investors are showing strong interest in newer, future-focused investments. Nearly half of Gen Z (46%) and Millennials (50%) hold cryptocurrency-themed ETFs—significantly higher ...

About This EventPopular, Inc. (Nasdaq: BPOP), the leading financial institution in Puerto Rico, visits the Nasdaq MarketSite in Times Square. Richard L. Carrión, Chairman of Popular’s Board of ...

Palantir Technologies (NASDAQ: PLTR) has been one of the hottest stocks on the market in recent years. Its share price has ...

Looking ahead to 2025, BP expects lower upstream production due to asset divestments in Egypt and Trinidad. Refining and fuel ...

Even a substantial and ongoing investment into the stock will struggle to turn into $1 million in 15 years. For example, if ...

While AMD, ASML, and Salesforce are great investments in their own right, they will be larger stocks than Palantir in three ...

Shares of Novo Nordisk (NYSE: NVO) are tumbling on Monday, down 5.6% as of 2:11 p.m. ET. The drop comes as the S&P 500 ...

Nasdaq was honored to host a special bell-ringing ceremony at the historic Philadelphia Stock Exchange (PHLX) to commemorate the U.S. Army’s 250th anniversary, a tribute to its enduring legacy of ...

High closing, also known as marking the close or painting the tape, was demonstrated by the regular upticking of the stock at the close. The closing price is a particularly important metric to ...